GT Biopharma, Inc. (GTBP)
0.4949
-0.04
(-8.16%)
USD |
NASDAQ |
Feb 09, 16:00
0.4852
-0.01
(-1.96%)
After-Hours: 18:20
GT Biopharma Market Cap : 5.264M for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 647.07M |
| Lyell Immunopharma, Inc. | 343.25M |
| Geron Corp. | 1.025B |
| Regeneron Pharmaceuticals, Inc. | 82.50B |
| Crinetics Pharmaceuticals, Inc. | 4.711B |
Market Cap Related Metrics
| Price to Book Value | 1.755 |
| Price | 0.4949 |
| Earnings Yield | -686.0% |